Supernus Pharmaceuticals, Inc. (SUPN)
USD 35.46
(-2.1%)
USD 35.46
(-2.1%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 529.01 Million USD | -20.38% |
| 2022 | 534.4 Million USD | 25.68% |
| 2021 | 425.21 Million USD | 45.45% |
| 2020 | 292.34 Million USD | 28.49% |
| 2019 | 227.52 Million USD | -8.66% |
| 2018 | 249.09 Million USD | 32.86% |
| 2017 | 187.48 Million USD | 26.0% |
| 2016 | 148.8 Million USD | 25.74% |
| 2015 | 118.33 Million USD | 28.55% |
| 2014 | 92.05 Million USD | 26.39% |
| 2013 | 72.83 Million USD | 66.87% |
| 2012 | 43.64 Million USD | 13.21% |
| 2011 | 38.55 Million USD | -4.16% |
| 2010 | 40.22 Million USD | 18.64% |
| 2009 | 33.9 Million USD | -2.42% |
| 2008 | 34.75 Million USD | 49.27% |
| 2007 | 23.28 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 111.48 Million USD | 0.59% |
| 2024 Q3 | 98.78 Million USD | 5.18% |
| 2024 Q1 | 110.83 Million USD | 6.55% |
| 2023 Q2 | 131.26 Million USD | 3.54% |
| 2023 Q1 | 126.77 Million USD | 12.75% |
| 2023 FY | 425.48 Million USD | -20.38% |
| 2023 Q4 | 104.02 Million USD | -17.83% |
| 2023 Q3 | 126.59 Million USD | -3.56% |
| 2022 Q4 | 112.44 Million USD | -26.27% |
| 2022 FY | 534.4 Million USD | 25.68% |
| 2022 Q3 | 152.51 Million USD | 10.91% |
| 2022 Q1 | 131.94 Million USD | -2.15% |
| 2022 Q2 | 137.5 Million USD | 4.22% |
| 2021 Q2 | 90.93 Million USD | -10.62% |
| 2021 FY | 425.21 Million USD | 45.45% |
| 2021 Q4 | 134.83 Million USD | 38.02% |
| 2021 Q1 | 101.74 Million USD | 26.66% |
| 2021 Q3 | 97.69 Million USD | 7.43% |
| 2020 Q3 | 77.6 Million USD | 6.61% |
| 2020 FY | 292.34 Million USD | 28.49% |
| 2020 Q1 | 61.81 Million USD | 11.34% |
| 2020 Q2 | 72.79 Million USD | 17.77% |
| 2020 Q4 | 80.32 Million USD | 3.5% |
| 2019 Q2 | 58.05 Million USD | 3.0% |
| 2019 FY | 227.52 Million USD | -8.66% |
| 2019 Q1 | 56.36 Million USD | -21.6% |
| 2019 Q4 | 55.51 Million USD | -3.6% |
| 2019 Q3 | 57.59 Million USD | -0.79% |
| 2018 Q3 | 61.31 Million USD | 1.96% |
| 2018 Q2 | 60.13 Million USD | 7.85% |
| 2018 Q1 | 55.75 Million USD | 11.65% |
| 2018 Q4 | 71.89 Million USD | 17.25% |
| 2018 FY | 249.09 Million USD | 32.86% |
| 2017 Q4 | 49.93 Million USD | -7.19% |
| 2017 FY | 187.48 Million USD | 26.0% |
| 2017 Q3 | 53.8 Million USD | 17.22% |
| 2017 Q2 | 45.9 Million USD | 21.31% |
| 2017 Q1 | 37.83 Million USD | -10.56% |
| 2016 FY | 148.8 Million USD | 25.74% |
| 2016 Q2 | 37.23 Million USD | 4.22% |
| 2016 Q4 | 42.3 Million USD | 26.13% |
| 2016 Q3 | 33.54 Million USD | -9.9% |
| 2016 Q1 | 35.72 Million USD | 8.21% |
| 2015 Q4 | 33.01 Million USD | 3.07% |
| 2015 FY | 118.33 Million USD | 28.55% |
| 2015 Q3 | 32.02 Million USD | 6.01% |
| 2015 Q2 | 30.21 Million USD | 30.88% |
| 2015 Q1 | 23.08 Million USD | -2.96% |
| 2014 Q2 | 24.25 Million USD | 10.22% |
| 2014 Q1 | 22 Million USD | 6.71% |
| 2014 Q4 | 23.79 Million USD | 8.14% |
| 2014 FY | 92.05 Million USD | 26.39% |
| 2014 Q3 | 22 Million USD | -9.31% |
| 2013 FY | 72.83 Million USD | 66.87% |
| 2013 Q4 | 20.62 Million USD | 12.1% |
| 2013 Q3 | 18.39 Million USD | 16.77% |
| 2013 Q2 | 15.75 Million USD | -12.73% |
| 2013 Q1 | 18.05 Million USD | 30.51% |
| 2012 Q2 | 9.34 Million USD | 15.61% |
| 2012 Q1 | 8.08 Million USD | -21.38% |
| 2012 Q3 | 12.38 Million USD | 32.45% |
| 2012 Q4 | 13.83 Million USD | 11.74% |
| 2012 FY | 43.64 Million USD | 13.21% |
| 2011 Q3 | 9.92 Million USD | 8.53% |
| 2011 Q4 | 10.28 Million USD | 3.62% |
| 2011 Q1 | 9.19 Million USD | -14.52% |
| 2011 FY | 38.55 Million USD | -4.16% |
| 2011 Q2 | 9.14 Million USD | -0.57% |
| 2010 Q4 | 10.76 Million USD | 0.0% |
| 2010 FY | 40.22 Million USD | 18.64% |
| 2009 FY | 33.9 Million USD | -2.42% |
| 2009 Q4 | 8.6 Million USD | 0.0% |
| 2008 FY | 34.75 Million USD | 49.27% |
| 2007 FY | 23.28 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Theratechnologies Inc. | 72.75 Million USD | -627.103% |
| Harrow Health, Inc. | 89.97 Million USD | -487.966% |
| Dynavax Technologies Corporation | 219.14 Million USD | -141.398% |
| Biofrontera Inc. | 39.95 Million USD | -1223.884% |
| Cronos Group Inc. | 96.7 Million USD | -447.013% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -5500.371% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | -127.9% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -1251.138% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 5633.009% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -1129.099% |
| Radius Health, Inc. | 265.92 Million USD | -98.929% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -3721.807% |
| DURECT Corporation | 43.71 Million USD | -1110.136% |
| ProPhase Labs, Inc. | 37.85 Million USD | -1297.577% |
| Safety Shot Inc | 12.1 Million USD | -4268.492% |
| Phibro Animal Health Corporation | 260.29 Million USD | -103.233% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -17136.188% |
| Alvotech | 285.43 Million USD | -85.333% |
| Assertio Holdings, Inc. | 368.58 Million USD | -43.525% |
| Rockwell Medical, Inc. | 15.37 Million USD | -3340.946% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -3930.723% |
| Procaps Group S.A. | 187.24 Million USD | -182.523% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 10.338% |
| SCYNEXIS, Inc. | 51.84 Million USD | -920.311% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -784.042% |
| Viatris Inc. | 5.96 Billion USD | 91.133% |
| OptiNose, Inc. | 85.1 Million USD | -521.62% |
| SIGA Technologies, Inc. | 22.04 Million USD | -2299.902% |
| Tilray Brands, Inc. | 251.35 Million USD | -110.462% |
| PetIQ, Inc. | 192.72 Million USD | -174.49% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -3930.723% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 66.864% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -5336.44% |
| Alimera Sciences, Inc. | 62.64 Million USD | -744.512% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -232.277% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -69279.22% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -8888.27% |
| Organogenesis Holdings Inc. | 314.13 Million USD | -68.403% |
| Journey Medical Corporation | 54.59 Million USD | -868.991% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -2870.548% |
| Alpha Teknova, Inc. | 45.85 Million USD | -1053.56% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -2398.989% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -978.778% |
| PainReform Ltd. | 9.58 Million USD | -5419.731% |
| Cosmos Health Inc. | 26.18 Million USD | -1920.608% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -220.679% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -5284.336% |
| Embecta Corp. | 528.4 Million USD | -0.116% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -13154.641% |
| Talphera, Inc. | 11.99 Million USD | -4310.63% |
| Pacira BioSciences, Inc. | 326.37 Million USD | -62.086% |
| Incannex Healthcare Limited | 30.05 Million USD | -1660.26% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -2414.061% |
| Shineco, Inc. | 17.94 Million USD | -2847.458% |
| Procaps Group, S.A. | 199.47 Million USD | -165.199% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | -169.927% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -1079.407% |
| Lantheus Holdings, Inc. | 344.9 Million USD | -53.381% |
| Alvotech | 285.43 Million USD | -85.333% |
| Hempacco Co., Inc. | 7.59 Million USD | -6863.925% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | -275.948% |
| Bright Green Corporation | 8.25 Million USD | -6310.023% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | -94.563% |
| Kamada Ltd. | 45.42 Million USD | -1064.556% |
| Indivior PLC | 911 Million USD | 41.931% |
| Evoke Pharma, Inc. | 12.4 Million USD | -4162.903% |
| Flora Growth Corp. | 10.57 Million USD | -4900.577% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -2414.061% |
| Evolus, Inc. | 189.75 Million USD | -178.78% |
| HUTCHMED (China) Limited | 436.23 Million USD | -21.269% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -243.215% |
| Akanda Corp. | 3.48 Million USD | -15086.157% |